6.78
price down icon8.63%   -0.64
after-market Dopo l'orario di chiusura: 6.78
loading

Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
1.04%
2.733
2.705 3.394 3.203 3.57
Operating Income/Loss
1.04%
-2.733
-2.705 -3.394 -3.203 -3.57
Income/Loss From Continuing Operations Before Tax
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Income/Loss From Continuing Operations After Tax
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Net Income/Loss
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
128.12%
43.04
18.87 15.17 0.1646 13.80
Diluted Average Shares
128.12%
43.04
18.87 15.17 0.1646 13.80
Basic Earnings Per Share
53.85%
-0.06
-0.13 -0.22 -0.22 -0.25
Diluted Earnings Per Share
53.85%
-0.06
-0.13 -0.22 -0.22 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):